Epicel and MACI are registered trademarks of Vericel Corporation. NexoBrid is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation. © 2024 Vericel Corporation. All rights reserved. Investor Contact: Eric Burns ir@vcel.com +1 (734) 418-4411 Media Contact: Julie Downs media@vcel.com CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that N ...

| --- | --- | --- | |-------------------------|-------|-------| | | | | | | | | | VERICEL Q1 2024 RESULTS | | | | MAY 8, 2024 | | | Q1 2024 Financial Highlights Profitability Growth Outpacing High Revenue Growth | --- | --- | --- | |-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------- ...

Vericel Corporation (NASDAQ:VCEL) Q1 2024 Earnings Conference Call May 8, 2024 8:30 AM ET Company Participants Eric Burns - Vice President of Finance & Investor Relations Nick Colangelo - Chief Executive Officer Joe Mara - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Sam Brodovsky - Truist Securities George Sellers - Stephens, Inc. Swayampakula Ramakanth - H.C. Wainwright Operator Ladies and gentlemen, thank you for standing by. Welcome to Vericel's First Quarter 2024 Conferenc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-35280 VERICEL CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identificat ...

Exhibit 99.1 Vericel Corporation 64 Sidney Street Cambridge, MA 02139 T 617 588-5555 F 617 588-5554 www.vcel.com Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance Total Revenue Increased 25% to $51.3 Million Record First Quarter MACI Revenue of $40.2 Million and Burn Care Revenue Growth of 63% Adjusted EBITDA Growth of 325% Full-Year 2024 Revenue Guidance Raised to $238-$242 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 8, 2024 (GL ...

Vericel Corporation (NASDAQ:VCEL) Q4 2023 Earnings Conference Call February 29, 2024 8:30 AM ET Company Participants Julie Downs - Head, Corporate Communications Nick Colangelo - President and CEO Joe Mara - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Mike Kratky - Leerink Partners Sam Brodovsky - Truist Securities George Sellers - Stephens Jeffrey Cohen - Ladenburg Swayampakula Ramakanth - HCW Operator Ladies and gentlemen, thank you for standing by. Welcome to Vericel’s Four ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION for the fiscal year ended December 31, 2023 Washington, D.C. 20549 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-35280 VERICEL CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No ...

Vericel Corporation (NASDAQ:VCEL) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET Company Participants Eric Burns - Vice President, Finance and Investor Relations Nick Colangelo - President and Chief Executive Officer Joe Mara - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Mike Kratky - Leerink Partners Jeffrey Cohen - Ladenburg Thalmann Samuel Brodovsky - Truist Securities George Sellers - Stephens Inc Arthur He - HCW Operator Ladies and gentlemen, thank you for s ...

▼VERICEL | --- | --- | --- | |-------------------------|-------|-------| | | | | | | | | | VERICEL Q3 2023 RESULTS | | | | NOVEMBER 8, 2023 | | | | --- | --- | --- | |-------------|-------|-------| | | | | | Safe Harbor | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------------------|---------------------------------------------------------------------------------------------------------|-----------------------------------------------------|-------|---------|--------------- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-35280 VERICEL CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identif ...